As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: May 20, 2015
by Alzheimer’s Society:
Higher levels of ferritin, an iron storage protein, may be associated with the transition from mild cognitive impairment (MCI) to Alzheimer’s disease, according to new research published today (Tuesday 19 May 2015) in Nature Communications.
Over a seven year period, researchers from the University of Melbourne monitored the cognitive performance of 91 cognitively normal individuals as well as 144 with mild cognitive impairment and 67 with Alzheimer’s disease. The study, which looked at various outcomes, found that higher levels of ferritin in cerebrospinal fluid in those with MCI were linked with an earlier conversion to Alzheimer’s . The researchers also found that ferritin was strongly linked to presence of the gene ApoE4, the strongest known Alzheimer’s disease risk gene.
Dr James Pickett, Head of Research at Alzheimer’s Society said:
‘Previous evidence suggests that an imbalance in iron in the brain may be linked to Alzheimer’s disease. This interesting study adds to these findings. The study, using seven years worth of data, finds that higher levels of the iron storage protein ferritin may be associated with people with mild cognitive impairment going on to develop Alzheimer’s disease earlier.
The biggest mistake we could make would be to take these results as meaning that a test for conversion from mild cognitive impairment to Alzheimer’s disease is around the corner. It’s not clear enough from this study whether iron levels could be used to predict this conversion with enough accuracy and we can’t draw any conclusions about whether we might be able to use iron as a target for future treatments. We need to see much more research into areas such as this which is why Alzheimer’s Society has pledged £100million for dementia research in the next ten years.’
Our bodies change as we age – partly due to natural physiological aging and partly due to lifestyle choices. As early as our thirties, we begin to lose a small amount of muscle mass, and,...
Utilizing tau PET imaging, new research finds tau to be a more accurate indication for future neurodegeneration, highlighting its potential for precision medicine-based treatment approaches. Amyloid-β has long been the bane of every Alzheimer’s researcher. Often found in...
It’s never too late to start working on brain health. That said, the strategies for how to optimize your brain will vary depending on several aspects, not the least of which is...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.
